Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Ascites and serial plasm circulating tumor DNA as a prognostic factor in peritoneal carcinomatosis after hyperthermic intraperitoneal chemotherapy.
Authors
Zongyuan Li
Graduate School of Dalian Medical University, Dalian, China
Zongyuan Li , Xiaolin Pu , Hua Jiang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
ChiCTR2000035025
DOI
10.1200/JCO.2022.40.4_suppl.661
Abstract #
661
Poster Bd #
M2
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Hyperthermic intraperitoneal chemotherapy post cytoreductive surgery in management of peritoneal carcinomatosis of colorectal primaries: Tertiary center experience.
First Author: Ahmed Badran Sobh
Poster
2023 ASCO Annual Meeting
Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma.
First Author: Christoffer Gebhardt
Poster
2019 ASCO Annual Meeting
Phase I trial of hyperthermic intraperitoneal chemoperfusion (HIPEC) with cisplatin, mitomycin, and paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology.
First Author: Brian D. Badgwell
Poster
2018 Gastrointestinal Cancers Symposium
Long-term survival of gastric cancer patients with positive immunocytochemistry peritoneal washings.
First Author: Katarzyna Marcisz-Grzanka